CAVA Group CAVA delivers 224 percent Q4 2025 revenue growth and strong EPS beat shares edge higher FBS Global FBGL Stock Correlation Slight Dip 20260420 LIXT Lixte posts Q4 2024 negative EPS of 27 cents and zero revenue with shares unchanged today FTAIM FTAI Q4 2025 EPS falls 16 percent short of estimates shares dip 025 percent in todays trading Marker Therapeutics MRKR Q4 2025 loss narrows unexpectedly beating estimates by 55 shares tick higher The biggest catalyst for Exicure XCUR nobody is watching 182 20260511 AGRO Adecoagro reports wide Q4 2025 EPS miss despite 169 percent revenue growth shares rise 2 percent Is Belden BDC stock worth evaluating for entry Ticks Higher 20260420 Bond Market Storm Weighs on Equities Analysts Warn of Growing Pressure News Analysis Fed officials are growing anxious about the Iran war